You have 9 free searches left this month | for more free features.

City

Boston (1)

Washington (1)

Condition

Acute Myeloid Leukemia (1)

Metastatic Pancreatic Ductal Adenocarcinoma (1)

Myelodysplastic Syndrome With Excess Blasts-2 (1)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Eric Stephen Winer, MD (1)

Georgetown University (1)

Collaborator

BioXcel Therapeutics Inc (1)

Intervention

bxcl701 (2)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

bxcl701

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting

Metastatic Pancreatic Ductal Adenocarcinoma

BXCL701
Pembrolizumab

Washington, District of Columbia

Georgetown Lombardi Comprehensive Cancer Center

Jan 23, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

Not yet recruiting

Acute Myeloid Leukemia
Myelodysplastic Syndrome With Excess Blasts-2

BXCL701

Boston, Massachusetts

Dana Farber Cancer Institute

Jan 26, 2023